Regulatory PathRegulatory requirements compared

Active substance

Cyproheptadine

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
PERIACTIN 4MG TABLETS4 mgTablet · Oral use20 BlisterSAR 5.20NCE · PrescriptionAlgorithm SALSuspended
CIPTADINE TAB 4MG4 mgTablet · Oral use20 BlisterSAR 2.70Generic · PrescriptionHikma Pharmaceuticals PLCWithdrawn by MAH · Not Marketed
PERIACTIN4 mgTablet · Oral use20 BlisterSAR 6.85NCE · PrescriptionMERCK SHARP & DOHMEWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralCHARTWELL RXPrescription26 May 1983
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralMOUNTAINPrescription30 Sep 2003
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralKENTONPrescription30 May 2006
CYPROHEPTADINE HYDROCHLORIDE2MG/5MLsyrup · oralRISINGPrescription28 Jun 2006
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralINGENUS PHARMS LLCPrescription23 Sep 2015
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralAPPCOPrescription29 Nov 2016
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralRISINGPrescription31 Jan 2017
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralZYDUS PHARMSPrescription19 May 2017
CYPROHEPTADINE HYDROCHLORIDE2MG/5MLsyrup · oralCHARTWELL MOLECULARPrescription13 Jul 2017
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralSTRIDES PHARMA INTLPrescription11 Apr 2018
CYPROHEPTADINE HYDROCHLORIDE2MG/5MLsyrup · oralST JOHN PHARMPrescription16 Oct 2018
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralREGCON HOLDINGSPrescription12 Apr 2019
CYPROHEPTADINE HYDROCHLORIDE2MG/5MLsyrup · oralQUAGENPrescription22 May 2019
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralQUAGENPrescription24 Feb 2021
CYPROLARA2MGtablet · oralQUAGENPrescription24 Feb 2021
PERIACTIN4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralMERCKDiscontinued17 Oct 1961
PERIACTIN2MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**syrup · oralMERCKDiscontinued30 Mar 1962
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralMYLANDiscontinued23 Apr 1979
CYPROHEPTADINE HYDROCHLORIDE4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralHERITAGE PHARMADiscontinued10 Jan 1980
CYPROHEPTADINE HYDROCHLORIDE2MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**syrup · oralACTAVIS MID ATLANTICDiscontinued16 Apr 1980
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralKV PHARMDiscontinued14 Oct 1980
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralCHARTWELL RXDiscontinued24 Feb 1981
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralSUPERPHARMDiscontinued18 May 1981
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralSTRIDES PHARMA INTLDiscontinued9 Jul 1981
CYPROHEPTADINE HYDROCHLORIDE4MGtablet · oralWATSON LABSDiscontinued14 Sep 1981

17 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
EURO-CYPROHEPTADINE 2MG/5ML024667322 MG / 5 MLSYRUP · ORALEURO-PHARM INTERNATIONAL CANADA INC
JAMP-CYPROHEPTADINE023322484 MGTABLET · ORALJAMP PHARMA CORPORATION
MAR-CYPROHEPTADINE025330654 MGTABLET · ORALMARCAN PHARMACEUTICALS INC

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACCYPROHEPTADINE 2 MG/5 ML SOLN$0.04186per ML23 Sep 2026
US NADACCYPROHEPTADINE 2 MG/5 ML SYRUP$0.04186per ML23 Sep 2026
US NADACCYPROHEPTADINE 4 MG TABLET$0.06787per EA23 Sep 2026
NHS Drug TariffCyproheptadine 4mg tablets£5.9930 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Combinations containing Cyproheptadine

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.